USPTO serial 79296717
KOMBOSCREEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- BLAZICH,JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with KOMBOSCREEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, and biological preparations, reagents and substances for scientific, research, laboratory and industrial purposes, all the aforesaid except for medical and veterinary purposes; diagnostic reagents, buffers, buffer solutions, buffer-screening stock solutions, ligands, hiv-immunogens, antibodies, namely, therapeutic antibodies, monoclonal antibodies, and antibody reagents, proteins, aptamers, antigens, biochemicals for in vitro and in vivo applications for scientific, research, laboratory, industrial and commercial purposes, all the aforesaid except for medical and veterinary purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical, biochemical, and biological preparations, reagents and substances for the development and production of diagnostic reagents and preparations, diagnostic kits, vaccines, pharmaceutical preparations and medicines and research in the fields of biology, biotechnology, biochemistry, chemistry, pharmacy and cosmetics, all the aforesaid except for medical and veterinary purposes; chemical, biochemical, and biological preparations, reagents and substances for scientific and medical research and medicine development; chemical, biochemical, and biological products, agents, compounds, preparations, reagents and substances for the manufacture of medicine and pharmaceutical preparations; chemical products, agents, compounds, preparations, reagents and substances for laboratory analysis, namely, bacterial preparations and bacteriological preparations, except for medical and veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 30, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 30, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 30, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 30, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 26, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 3, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 29, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 9, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 21, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 1, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |